[1]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50-54.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
　Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50-54.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
点击复制

全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
40
期数:
2016年第1期
页码:
50-54
栏目:
出版日期:
2016-01-25

文章信息/Info

Title:
Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration
作者:
岳进1;  苏丽萍2
1. 030001 太原, 山西医科大学研究生学院;
2. 030013 太原, 山西医科大学附属肿瘤医院血液科
Author(s):
Yue Jin1;  Su Lipin2
1. Department of Graduated, Shanxi Medical University, Taiyuan 030001, China;
2. Departmemt of Hematology, Affiliated Shanxi Tumor Hospital, Shanxi Medical University, Taiyuan 030013, China
关键词:
淋巴瘤; 磁共振成像; 正电子发射断层摄影术; 体层摄影术; X线计算机; 骨髓浸润; 预后
Keywords:
Lymphoma; Magnetic resonance imaging; Positron-emission tomography; Tomography; X-ray computed; Bone marrow infiltration; Prognosis
DOI:
10.3760/cma.j.issn.1673-4114.2016.01.010
摘要:
淋巴瘤是一种血液系统恶性肿瘤。淋巴瘤骨髓浸润(BMI)使疾病分期上升至IV期,是疾病进展、预后较差的标志。常规部位的骨髓活检(BMB)具有创伤性,且检出率低。PET/CT与全身MRI的出现,丰富了BMI的检测手段。PET/CT与全身MRI对于淋巴瘤,尤其是侵袭性淋巴瘤BMI均具有较高的检出率,二者孰高孰低,尚未定论。对于红骨髓、良性骨髓病变(炎症等)、淋巴瘤BMI病灶以及肿瘤治疗后骨髓的变化与骨髓残留或复发病灶,全身MRI很难区分,而PET/CT却可以很好地鉴别这些病灶。但是,PET/CT存在电离辐射;对于惰性淋巴瘤的BMI,超出PET/CT分辨率的病灶,可能出现假阴性;某些情况会限制PET/CT的使用,包括18F-FDG生理性摄取量可能发生改变的正常组织、18F-FDG摄取相关性炎症、高血糖或高胰岛素血症导致的18F-FDG分布的改变、肿瘤患者治疗后出现的骨髓活化等。然而,这些情况可以使用全身MRI。因此,全身MRI和PET/CT相辅相成,优势互补,但二者均不能代替BMB。对于常规BMB阴性,但影像学提示阳性的患者,在影像学引导下进行BMB,可以提高BMI的检出率。另外,全身MRI阳性的淋巴瘤BMI患者与全身MRI阴性的淋巴瘤BMI患者相比,前者预后可能较差。
Abstract:
Lymphoma is a malignant tumor of the blood system.Bone marrow infiltration(BMI) advances the disease to stage IV and is a marker of disease progression and poor prognosis.Conventional bone marrow biopsy is a traumatic detection,and the rate is low.The emergence of PET/CT and whole-body MRI supplements the means of BMI detection.PET/CT and whole-body MRI both exhibit a high detection rate for lymphoma BMI,particularly for aggressive lymphoma BMI.However,both approaches to determine high and low is inconclusive,For red bone marrow,benign bone marrow lesions(inflammation and others),lymphoma BMI lesions,as well as bone marrow changes after tumor therapy and bone marrow residual or recurrent lesions,whole body MRI is difficult to distinguish.PET/CT can excellently identify these lesions.However,PET/CT uses ionizing radiation:false negative results can be present for inert lymphoma BMI lesions and lesions beyond the PET/CT resolution.Certain circumstances may limit the use of PET/CT,including normal tissue,whose 18F-FDG physiological uptake may change;inflammation,which is related to 18F-FDG uptake,changes in the distribution of 18F-FDG caused by high blood glucose or high blood insulin,bone marrow activation in tumor patients after treatment,and so on.In these cases,we can use whole-body MRI.Therefore,the two approaches are complementary.Neither PET/CT nor whole body MRI can replace BMB.BMB under the guidance of PET/CT or whole-body MRI considerably improves the detection rate of BMI for patients with negative BMB findings,but imaging findings are positive.In addition,whole-body MRI-positive patients may present poorer prognosis than whole-body MRI-negative patients.

参考文献/References:

[1] Kwee TC,Kwee RM,Verdonck LF,et al.Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma[J].Br JHaematol,2008,141(1):60-68.DOI:10.1111/j.1365-2141.2008.07020.x.
[2] Adams HJ,Kwee TC,Vermoolen MA,et al.Whole-body MRI for the detection of bone marrow involvement in lymphoma:prospective study in 116 patients and comparison with FDG-PET[J].Eur Radiol,2013,23(8):2271-2278.DOI:10.1007/s00330-013-2835-9.
[3] Daldrup-Link HE,Henning T,Link TM.MR imaging of therapy-induced changes of bone marrow[J].Eur radiol,2007,17(3):743-761.DOI:10.1007/s00330-006-0404-1.
[4] Nakanishi K,Kobayashi M,Nakaguchi K,et al.Whole-body MRI for detecting metastatic bone tumor:diagnostic value of diffusion-weighted images[J].Magn Reson Med Sci,2007,6(3):147-155.DOI:10.2463/mrms.6.147.
[5] Takenaka D,Ohno Y,Matsumoto K,et al.Detection of bone metastases in non-small cell lung cancer patients:Comparison of whole-body diffusion-weighted imaging(DWI),whole-body MR imaging without and with DWI,whole-body FDG-PET/CT,and bone scintigraphy[J].J Magn Reson Imaging,2009,30(2):298-308.DOI;10.1002/jmri.21858.
[6] Adams HJA,Kwee TC,Vermoolen MA,et al.Whole-body MRI for the detection of bone marrow involvement in lymphoma:prospective study in 116 patients and comparison with FDG-PET[J].Eur radiol,2013,23(8):2271-2278.DOI:10.1007/s00330-013-2835-9.
[7] Kwee TC,Fijnheer R,Ludwig I,et al.Whole-body magnetic resonace imaging,including diffusion-weighted imaging,for diagnosing bone marrow involvement in malignant lymphoma[J].Br J Haematol,2010,149(4):628-630.DOI:10.1111/j.1365-2141.2010.08093.x.
[8] Brennan DD,Gleeson T,Coate LE,et al.A comparison of whole-body MRI and CT for the staging of lymphoma[J].AJR Am J Roentqenol,2005,185(3):711-716.
[9] 汤日杰,桂思,李建生,等.18F-FDG PET/CT与大范围弥散磁共振成像评价非霍奇金淋巴瘤骨髓浸润的对比研究[J].中华血液学杂志,2014,35(3):231-235.DOI:10.3760/cma.j.issn.0253-2727.2014.03.011.Tang RJ,Gui S,Li JS,et al.Comparison of 18F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration[J].Chin J Hemorhed,2014,35(3):231-235.
[10] Kwee TC,Ludwig I,Uiterwaal CS,et al.ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphom a:feasibility study[J].Magn Res Mater Phy,Biol Med,2011,24(1):1-8.DOI:10.1007/s10334-010-0226-7.
[11] Kwee TC,de Klerk JM,Nievelstein RA.Imaging of bone marrow invo lvement in lymphoma:state of the art and future directions[J].Sci World J,2011,11:391-402.DOI:10.1100/tsw.2011.40.
[12] Howe BM,Johnson GB,Wenger DE.Current concepts in MRI of focal and diffuse malignancy of bone marrow[J].Semin Musculoskelet Radiol.2013,17(2):137-144.DOI:10.1055/s-0033-1343069.
[13] Basu S,Torigian D,Alavi A.Evolving concept of imaging bone marrow metastasis in the twenty-first century:critical role of FDG-PET[J].Eur J Nucl Med Mol imaging,2008,35(3):465-471.
[14] Adams HJA,Kwee TC,Lokhorst HM,et al.Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy[J].J Magn Reson Imaging,2014,39(6):1394-1400.DOI:10.1002/jmri.24318.
[15] Tsunoda S,Takagi S,Tanaka O,et al.Clinical and prognostic significance of femoral marrow magnetic resonance imaging in patients with malignant lymphoma[J].Blood,1997,89(1):286-290.
[16] Ribrag V,Vanel D,Leboulleux S,et al.Prospective study of bone marrow infiltration in aggressive lymphoma by three independe nt methods:whole-body MRI,PET/CT and bone marrow biopsy[J].Eur J Radiol,2008,66(2):325-331.DOI:10.1016/j.ejrad.2007.06.014.
[17] 闫瑾,林祥通.PET预测及评价肿瘤疗效的新进展[J].国际放射医学核医学杂志,2006,30(4):214-217.Yan J,Lin ST.The new advance of predication and advalution of tumor thera peutic effects by PET[J].Inter J Radiat Med Nucl Med,2006,30(4):214-217.
[18] Khan AB,Barrington SF,Mikhaeel NG,et al.PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement[J].Blood,2013,122(1):61-67.DOI:10.1182/blood-2012-12-473389.
[19] El-Galaly TC,d’Amore F,Mylam KJ et al.Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma[J].J Clin Oncol,2012,30(36):4508-4514.DOI:10.1200/JCO.2012.42.4036.
[20] Littooij AS,Kwee TC,Barber I,et al.Whole-body MRI for initial staging of paediatric lymphoma:prospective comparison to an FDG-PET/CT-based reference standard[J].Eur Radiol,2014,24(5):1153-1165.DOI:10.1007/s00330-014-3114-0.
[21] Ferrari1 C,Minoia C,Asabella AN,et al.Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to 18F-FDG PET/CT in newly FDG PET/CT in newly diagnosed lymphoma diagnosed lymphoma[J].Hell J Nucl Med,2014,Suppl1:40-49.
[22] Abdulqadhr G,Molin D,Astrom G,et al.Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients[J].Acta Radiol,2011,52(2):173-180.DOI:10.1258/ar.2010.100246.
[23] Wu X,Kellokumpu-Lehtinen PL,Pertovaara H,et al.Diffusion-weighted MRI in early chemotherapy response evaluation of patientswith diffuse large B-cell lymphoma-a pilot study:comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/computed tomography[J].NMR Biomed,2011,24(10):1181-1190.DOI;10.1002/nbm.1689.
[24] Marina V,Milena R,Vesna P,et al.Complementary roles of bone scintigraphy and MR imaging in the detection and long-term follow-up of primary non-Hodgkin’s bone lymphoma in a child-case report[J].Skeletal Radiol,2015,44(6):863-868.DOI:10.1007/s00256-014-2067-3.

相似文献/References:

[1]李敏,蒋涛,彭朋,等.直肠内注入模拟粪便的动态MRI对女性盆底痉挛综合征的诊断价值[J].国际放射医学核医学杂志,2016,40(3):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
　Li Min,Jiang Tao,Peng Peng,et al.Value of dynamic MRI with rectum injection in the diagnosis of female spastic pelvic floor syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
[2]唐令胜,刘朝晖,李红梅,等.低场磁共振DWI技术与常规MRI扫描对超急性脑梗死的诊断灵敏度的比较[J].国际放射医学核医学杂志,2016,40(3):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
　Tang Lingsheng,Liu Zhaohui,Li Hongmei,et al.Comparison of the diagnostic sensitivity of low-field magnetic resonance diffusion weighted imaging technology and conventional MRI scanning for super acute cerebral infarction[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
[3]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
　You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[4]贺小红,周新韩,高明勇,等.模型模拟修改部分扫描参数加速MR扫描的方法可行性探讨[J].国际放射医学核医学杂志,2016,40(4):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
　He Xiaohong,Zhou Xinhan,Gao Mingyong,et al.Feasibility of accelerating MR scan by modifying part of scanning parameters：a phantom simulation study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
[5]卢瑞梁,贺小红,蔡华清,等.不同MRI序列检出聚丙烯酰胺水凝胶注射隆乳患者乳腺病变效能的比较研究[J].国际放射医学核医学杂志,2016,40(6):435.[doi:10.3760/cma.j.issn.1673-4114.2016.06.007]
　Lu Ruiliang,He Xiaohong,Cai Huaqing,et al.The different MRI sequences to detect breast lesions in polyacrylamide hydrogel injection for augmentation patients: a comparative study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):435.[doi:10.3760/cma.j.issn.1673-4114.2016.06.007]
[6]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
　Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[7]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
　Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[8]周金鑫,张一帆.胰岛细胞移植监测的分子影像学进展[J].国际放射医学核医学杂志,2015,39(6):478.[doi:10.3760/cma.j.issn.1673-4114.2015.06.009]
　Zhou Jinxin,Zhang Yifan.Research progress of molecular imaging in monitoring islet transplantation[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):478.[doi:10.3760/cma.j.issn.1673-4114.2015.06.009]
[9]樊鹏,甄俊平,王峻.MR示踪技术在干细胞移植治疗软骨缺损中的研究进展[J].国际放射医学核医学杂志,2015,39(6):497.[doi:10.3760/cma.j.issn.1673-4114.2015.06.013]
　Fan Peng,Zhen Junping,Wang Jun.The progress of magnetic resonance cell tracing technique in stem cells transplantation treatment of cartilage defects[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):497.[doi:10.3760/cma.j.issn.1673-4114.2015.06.013]
[10]张学花,翟昭华.胰腺微囊性腺瘤影像学报道一例[J].国际放射医学核医学杂志,2015,39(6):516.[doi:10.3760/cma.j.issn.1673-4114.2015.06.019]
[11]戴娜,吴翼伟.影像学技术在霍奇金淋巴瘤诊疗中的价值[J].国际放射医学核医学杂志,2014,38(2):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
　Dai Na,Wu Yiwei.The value of medical imaging methods in diagnosis and treatment of Hodgkin lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
[12]杨希,党春江.泌尿系统原发性结外淋巴瘤的临床及影像学表现[J].国际放射医学核医学杂志,2013,37(4):230.[doi:10.3760/cma.j.issn.1673-4114.2013.04.010]
　YANG Xi,DANG Chun-jiang.The clinical and imaging appearances of primary extranodal lymphoma of the urinary system[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):230.[doi:10.3760/cma.j.issn.1673-4114.2013.04.010]

备注/Memo

备注/Memo:
收稿日期:2015-08-05;改回日期:。
基金项目:山西省卫生厅科技攻关计划项目(2011044)
通讯作者:苏丽萍
更新日期/Last Update: 1900-01-01